Literature DB >> 2555413

Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway.

D L Anderson1, C D Tsoukas.   

Abstract

The catalytic subunit of cholera toxin (CT) can chemically modify the alpha polypeptides of certain G-binding proteins and thus alter their function. In order to study the involvement of CT-sensitive G proteins in T cell activation, we have utilized CT in an in vitro system in which purified, resting human peripheral T cells are activated by anti-CD3 antibodies and rIL-2. Perturbation of the TCR/CD3 molecular complex by anti-CD3 antibodies causes changes in membrane phospholipids and induces a rise in cytoplasmic Ca2+. These events, however, are insufficient to allow progression into cellular proliferation and addition of IL-2 is required. Under these conditions, treatment of cells with a low concentration of CT (2 ng/ml) causes a significant inhibition of the anti-CD3-induced calcium event as well as the anti-CD3 plus IL-2-stimulated proliferation. Under our experimental conditions, inhibition of both proliferation and intracellular Ca2+ elevation by CT requires the involvement of the TCR/CD3 complex. This is supported by the observation that the toxin does not inhibit either the proliferation triggered by ionomycin and PMA or the Ca2+ influx induced by the ionophore. These data suggest that in TCR/CD3-mediated T cell activation CT acts at a point between TCR/CD3 perturbation and the generation of intracellular Ca2+. In view of the ability of CT to activate the alpha subunit of the G protein that stimulates adenyl cyclase (G alpha s), it is possible that the effect of CT on T cells is secondary to intracellular elevation of cAMP. However, measurement of cAMP levels both early after CT addition and at later time points, when proliferation is maximal, reveals lack of cyclic nucleotide accumulation. The presented data are consistent with the interpretation that the CT-mediated inhibition is caused by the modification of a G-binding protein that is either directly or indirectly associated with triggering of T cells via the TCR/CD3 molecular complex. The data also suggest that this protein is not G alpha s and it probably represents an as yet unidentified moiety or one of the several G proteins that have been recently described as regulators of phospholipase C activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555413

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Differential effect of cholera toxin on CD45RA+ and CD45RO+ T cells: specific inhibition of cytokine production but not proliferation of human naive T cells.

Authors:  K Eriksson; I Nordström; C Czerkinsky; J Holmgren
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Molecular effects of cholera toxin on isotype differentiation.

Authors:  N Lycke; E Severinson; W Strober
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Expression of GTP-binding protein alpha subunits in human thymocytes.

Authors:  P S Kabouridis; S T Waters; S Escobar; J Stanners; C D Tsoukas
Journal:  Mol Cell Biochem       Date:  1995-03-09       Impact factor: 3.396

4.  Selection of a WEHI-3B leukemia cell subclone resistant to inhibition by cholera toxin.

Authors:  Augusto Pessina; Attilia Giuliani; Cristina Croera; Paola Foti; Lucia Mascolo; Giuseppina Gagliardi; Maria Grazia Neri
Journal:  Mol Cell Biochem       Date:  2002-04       Impact factor: 3.396

5.  Cholera toxin inhibits interleukin-2-induced, but enhances pertussis toxin-induced T-cell proliferation: regulation by cyclic nucleotides.

Authors:  A A Maghazachi
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

Review 6.  Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin.

Authors:  B D Spangler
Journal:  Microbiol Rev       Date:  1992-12

7.  Uncovering a novel role of PLCβ4 in selectively mediating TCR signaling in CD8+ but not CD4+ T cells.

Authors:  Miwa Sasai; Ji Su Ma; Masaaki Okamoto; Kohei Nishino; Hikaru Nagaoka; Eizo Takashima; Ariel Pradipta; Youngae Lee; Hidetaka Kosako; Pann-Ghill Suh; Masahiro Yamamoto
Journal:  J Exp Med       Date:  2021-05-10       Impact factor: 14.307

Review 8.  Toxins-useful biochemical tools for leukocyte research.

Authors:  Susana Cubillos; Johannes Norgauer; Katja Lehmann
Journal:  Toxins (Basel)       Date:  2010-03-26       Impact factor: 4.546

9.  A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.

Authors:  S Yamamoto; H Kiyono; M Yamamoto; K Imaoka; K Fujihashi; F W Van Ginkel; M Noda; Y Takeda; J R McGhee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

10.  Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression.

Authors:  M C Braun; J He; C Y Wu; B L Kelsall
Journal:  J Exp Med       Date:  1999-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.